Donald DeGolyer - Endo International Insider

ENDP -- USA Stock  

USD 11.10  0.11  0.98%

Special Advisor to the CEO
Mr. Donald W. Degolyer is a Chief Operating Officer Pharmaceuticals.
Age: 53        
353 1 268 2000

Donald DeGolyer Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.03 % which means that it generated profit of $3.03 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of (143.52) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 8.27 B in liabilities. Endo International plc has Current Ratio of 1.04 suggesting that it is not liquid enough and may have problems to pay out its financial obligations when they are due.

Similar Executives

Entity Summary

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Endo International operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 30 people.Endo International plc (ENDP) is traded on BATS Exchange in USA. It is located in IRELAND and employs 3,039 people. Endo International is listed under Pharmaceutical Products category by Fama And French industry classification.

Endo International plc Leadership Team

Carrie Nichol, President, MBA
William Spengler, Director
Arthur Higgins, Director
Brian Lortie, President
Donald DeGolyer, CEO
William Montague, Director
Michael Hyatt, Director
Douglas Ingram, Director
Antonio Pera, President, MBA
Roger Kimmel, Chairman
Susan Hall, EVP, Ph.D
Sharad Mansukani, Director
Suketu Upadhyay, CFO, CPA
Nancy Hutson, Director
Todd Sisitsky, Director, MBA
Patrick Barry, President, MBA
Shane Cooke, Director
Craig Paterson, Executive, MBA
Daniel Rudio, President
Camille Farhat, President, MBA
Paul Campanelli, CEO
Jill Smith, Director
Rajiv Silva, CEO
Nina Goworek, Director
Blaise Coleman, President, MBA
Terrance Coughlin, President
Matthew Maletta, President

Stock Performance Indicators

Current Sentiment - ENDP

Endo International plc Investor Sentiment
Most of Macroaxis users are currently bullish on Endo International plc. What is your opinion about investing in Endo International plc? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Endo International and Diplomat Pharmacy. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.